Dual-Acting Antibiotics Offer Hope Against Superbugs
Researchers from Wistar Institute have found a new category of compounds that merge the killing of bacterial pathogens that are drug resistant through the use of antibiotics, with a swift immune response used to fight antimicrobial resistance. Last year, the WHO declared antimicrobial resistance (AMR) as a top public health threat. Estimates show that by the year 2050, infections that are antibiotic resistant could not only thrust upon the world economy a collective burden of $100 trillion but also claim the lives of nearly 10 million people every year. It does not help that the number of bacteria growing treatment…